Catalyst Wire Dossier Catalyst Wire Dossier

Cevira

· Asieris MediTech (Hong Kong) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cevira, covering 2022-08-12 to 2022-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) [Phase 3]

See pricing